The investment seeks long-term growth of capital... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category AggressiveAllocation
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MAPLX | 27.16 | 0.58 | +2.18% |
| Morgan Stanley Inst Advantage L | |||
| NMANX | 15.30 | 0.16 | +1.06% |
| Neuberger Mid Cap Growth Inv | |||
| TMCGX | 17.10 | 0.14 | +0.83% |
| Thrivent Mid Cap Growth S | |||
| RMQAX | 631.83 | 3.78 | +0.60% |
| Rydex Monthly Rbl NASDAQ-100® 2x Strt A | |||
| FCIGX | 43.99 | N/A | N/A |
| Fidelity Advisor Small Cap Growth I | |||
A.I.dvisor indicates that over the last year, FERAX has been closely correlated with RIRAX. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if FERAX jumps, then RIRAX could also see price increases.
| Ticker / NAME | Correlation To FERAX | 1D Price Change % | ||
|---|---|---|---|---|
| FERAX | 100% | +1.81% | ||
| RIRAX - FERAX | 88% Closely correlated | +0.50% | ||
| CIREX - FERAX | 87% Closely correlated | +0.51% | ||
| CIRAX - FERAX | 87% Closely correlated | +0.51% | ||
| RIRGX - FERAX | 87% Closely correlated | +0.51% | ||
| CAIBX - FERAX | 87% Closely correlated | +0.50% | ||
More | ||||